Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
TRAX	0	broad.mit.edu	37	1	231954287	231954287	+	3'UTR	SNP	C	C	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr1:231954287C>A	ENST00000602962.1	+	0	2854				DISC1_ENST00000537876.1_Intron|DISC1_ENST00000366633.3_Intron|DISC1_ENST00000602873.1_3'UTR|DISC1_ENST00000539444.1_3'UTR|DISC1_ENST00000439617.2_Intron|DISC1_ENST00000535983.1_Intron|DISC1_ENST00000602281.1_3'UTR|DISC1_ENST00000366636.4_Intron|DISC1_ENST00000366637.3_Intron						NA		NA									NA						AACTGTTCCCCGGCAAGATAT	0.468		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		42	43	43	NA	NA	NA	NA	1	NA	NA		NA						NA			NA				231954287		2203	4300	6503	SO:0001624	3_prime_UTR_variant								NA		ENST00000602962.1	37																																																																																				TRAX-003	KNOWN	basic|readthrough_transcript	nonsense_mediated_decay	NA	protein_coding	OTTHUMT00000467442.1	1.002543	KEEP		+	6.568143	0.090909	3	30	---	---	---	---	1	0.2773307	9	0	0	39	3	30	0	39	2	0	0	0	0	0	0	3	30	0	39	2	TP
FN1	2335	broad.mit.edu	37	2	216245443	216245443	+	Intron	SNP	G	G	T			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr2:216245443G>T	ENST00000354785.4	-	33	5804				FN1_ENST00000346544.3_Intron|FN1_ENST00000490833.1_Intron|FN1_ENST00000432072.2_Intron|FN1_ENST00000421182.1_Intron|FN1_ENST00000357867.4_Intron|FN1_ENST00000357009.2_Intron|FN1_ENST00000356005.4_Intron|FN1_ENST00000345488.5_Intron|FN1_ENST00000323926.6_Intron|FN1_ENST00000336916.4_Intron|FN1_ENST00000359671.1_Intron|FN1_ENST00000443816.1_Intron|FN1_ENST00000446046.1_Intron			P02751	FINC_HUMAN	fibronectin 1	NA		NA			acute-phase response|angiogenesis|leukocyte migration|peptide cross-linking|platelet activation|platelet degranulation|regulation of cell shape|substrate adhesion-dependent cell spreading	ER-Golgi intermediate compartment|fibrinogen complex|platelet alpha granule lumen|proteinaceous extracellular matrix	collagen binding|extracellular matrix structural constituent|heparin binding		FN1/ALK(2)	NS(1)|autonomic_ganglia(1)|breast(2)|central_nervous_system(7)|endometrium(9)|kidney(8)|large_intestine(33)|lung(38)|ovary(1)|pancreas(1)|prostate(3)|skin(1)|stomach(2)|upper_aerodigestive_tract(2)	109		Renal(323;0.127)		Epithelial(149;9.59e-07)|all cancers(144;0.000174)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00948)	Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Tenecteplase(DB00031)	ACCCTTACACGGGAATCAATA	0.398		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		NA	NA	NA	NA	NA	NA	NA		NA	NA		NA						NA			NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000115414	HGNC:3778	NM_212476	Approved	uc002vfa.3	NA	O95609|O95610|Q14312|Q14325|Q14326|Q17RV7|Q585T2|Q59EH1|Q60FE4|Q68DP8|Q68DP9|Q68DT4|Q6LDP6|Q6MZS0|Q6MZU5|Q6N025|Q6N0A6|Q86T27|Q8IVI8|Q96KP7|Q96KP8|Q96KP9|Q9H1B8|Q9HAP3|Q9UMK2	ENST00000354785.4	37	CCDS42814.1																																																																																			FN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256667.2	-24.79739	KEEP		-	7.419546	0.030075	4	129	---	---	---	---	1	0.9376388	7299	16	1	158	4	133	1	158	122	0	0	0	0	0	0	4	133	1	158	2	TP
CTNNB1	1499	broad.mit.edu	37	3	41277276	41277276	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr3:41277276G>T	ENST00000349496.5	+	11	2025	c.1745G>T	c.(1744-1746)cGg>cTg	p.R582L	CTNNB1_ENST00000453024.1_Missense_Mutation_p.R575L|CTNNB1_ENST00000405570.1_Missense_Mutation_p.R582L|CTNNB1_ENST00000396183.3_Missense_Mutation_p.R582L|CTNNB1_ENST00000396185.3_Missense_Mutation_p.R582L	NM_001904.3	NP_001895.1	P35222	CTNB1_HUMAN	catenin (cadherin-associated protein), beta 1, 88kDa	582		NA			adherens junction assembly|androgen receptor signaling pathway|branching involved in ureteric bud morphogenesis|canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis|canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition|cell-cell adhesion|cell-matrix adhesion|cellular component disassembly involved in apoptosis|cellular response to growth factor stimulus|cellular response to indole-3-methanol|central nervous system vasculogenesis|cytoskeletal anchoring at plasma membrane|determination of dorsal/ventral asymmetry|dorsal/ventral axis specification|ectoderm development|embryonic axis specification|embryonic foregut morphogenesis|embryonic leg joint morphogenesis|endodermal cell fate commitment|endothelial tube morphogenesis|epithelial to mesenchymal transition|gastrulation with mouth forming second|glial cell fate determination|hair follicle morphogenesis|hair follicle placode formation|hindbrain development|liver development|lung cell differentiation|lung induction|lung-associated mesenchyme development|male genitalia development|mesenchymal cell proliferation involved in lung development|mesenchymal to epithelial transition involved in metanephros morphogenesis|negative regulation of cell proliferation|negative regulation of chondrocyte differentiation|negative regulation of heart induction by canonical Wnt receptor signaling pathway|negative regulation of osteoclast differentiation|negative regulation of transcription from RNA polymerase II promoter|nephron tubule formation|odontogenesis of dentine-containing tooth|oocyte development|pancreas development|positive regulation of anti-apoptosis|positive regulation of apoptosis|positive regulation of branching involved in lung morphogenesis|positive regulation of epithelial cell proliferation involved in prostate gland development|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of heparan sulfate proteoglycan biosynthetic process|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of MAPKKK cascade|positive regulation of muscle cell differentiation|positive regulation of osteoblast differentiation|positive regulation of transcription from RNA polymerase II promoter|protein localization at cell surface|proximal/distal pattern formation|regulation of angiogenesis|regulation of calcium ion import|regulation of centriole-centriole cohesion|regulation of centromeric sister chromatid cohesion|regulation of fibroblast proliferation|regulation of nephron tubule epithelial cell differentiation|regulation of protein localization at cell surface|regulation of smooth muscle cell proliferation|regulation of T cell proliferation|renal inner medulla development|renal outer medulla development|renal vesicle formation|response to drug|response to estradiol stimulus|Schwann cell proliferation|smooth muscle cell differentiation|synapse organization|synaptic vesicle transport|T cell differentiation in thymus|thymus development|trachea formation	APC-Axin-1-beta-catenin complex|Axin-APC-beta-catenin-GSK3B complex|beta-catenin-TCF7L2 complex|catenin complex|cell cortex|cell-substrate adherens junction|centrosome|dendritic shaft|desmosome|fascia adherens|internal side of plasma membrane|lamellipodium|lateral plasma membrane|microvillus membrane|perinuclear region of cytoplasm|protein-DNA complex|synapse|transcription factor complex|Z disc|zonula adherens	alpha-catenin binding|androgen receptor binding|cadherin binding|estrogen receptor binding|I-SMAD binding|ion channel binding|protein binding|protein C-terminus binding|protein kinase binding|protein phosphatase binding|R-SMAD binding|RPTP-like protein binding|signal transducer activity|specific RNA polymerase II transcription factor activity|structural molecule activity|transcription coactivator activity|transcription regulatory region DNA binding	p.R582Q(1)	CTNNB1/PLAG1(60)	NS(4)|adrenal_gland(103)|biliary_tract(43)|bone(21)|breast(7)|central_nervous_system(260)|cervix(9)|endometrium(293)|eye(1)|haematopoietic_and_lymphoid_tissue(60)|kidney(202)|large_intestine(269)|liver(1010)|lung(63)|oesophagus(6)|ovary(106)|pancreas(126)|parathyroid(11)|pituitary(111)|pleura(2)|prostate(31)|salivary_gland(13)|skin(103)|small_intestine(17)|soft_tissue(792)|stomach(165)|thyroid(55)|upper_aerodigestive_tract(2)|urinary_tract(8)	3893				KIRC - Kidney renal clear cell carcinoma(284;0.0028)|Kidney(284;0.00294)	Lithium(DB01356)	ATCCTAGCTCGGGATGTTCAC	0.428		15	"""H, Mis, T"""	PLAG1	"""colorectal, cvarian,  hepatoblastoma, others, pleomorphic salivary adenoma"""				Pilomatrixoma, Familial Clustering of					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(6;3 56 14213 18255)		Dom	yes		3	3p22-p21.3	1499	"""catenin (cadherin-associated protein), beta 1"""		"""E, M, O"""	1	Substitution - Missense(1)	large_intestine(1)					NA				NA		169	166	167	NA	NA	NA	NA	3	NA	NA		NA						NA			NA				41277276		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Pilomatricoma, Familial Clustering of, Epithelioma Calcificans of Malherbe	ENSG00000168036	HGNC:2514	NM_001098210	Approved	uc003ckr.2	NA	A8K1L7|Q8NEW9|Q8NI94|Q9H391	ENST00000349496.5	37	CCDS2694.1	.	.	.	.	.	.	.	.	.	.	G	36	5.794648	0.96952	.	.	ENSG00000168036	ENST00000405570;ENST00000396183;ENST00000349496;ENST00000453024;ENST00000396185	T;T;T;T;T	0.64438	-0.1;-0.1;-0.1;-0.1;-0.1	5.62	5.62	0.85841	Armadillo-like helical (1);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	D	0.84442	0.5473	M	0.92970	3.365	0.80722	D	1	D;D;D	0.89917	0.989;1.0;0.989	P;D;P	0.91635	0.817;0.999;0.817	D	0.85342	0.1096	10	0.39692	T	0.17	-10.1887	19.661	0.95871	0.0:0.0:1.0:0.0	.	510;17;582	B4DSW9;P35222-2;P35222	.;.;CTNB1_HUMAN	L	582;582;582;575;582	ENSP00000385604:R582L;ENSP00000379486:R582L;ENSP00000344456:R582L;ENSP00000411226:R575L;ENSP00000379488:R582L	ENSP00000344456:R582L	R	+	2	0	CTNNB1	41252280	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	9.869000	0.99810	2.659000	0.90383	0.655000	0.94253	CGG	CTNNB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254182.2	-26.708143	KEEP		+	6.390494	0.029412	4	132	---	---	---	---	1	0.9999991	2	3017	0	136	4	134	0	136	2	0	0	0	0	0	0	4	134	0	136	2	TP
TIPARP	25976	broad.mit.edu	37	3	156411902	156411902	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr3:156411902C>A	ENST00000461166.1	+	3	1599	c.1011C>A	c.(1009-1011)agC>agA	p.S337R	TIPARP_ENST00000486483.1_Missense_Mutation_p.S337R|TIPARP_ENST00000542783.1_Missense_Mutation_p.S337R|TIPARP_ENST00000295924.7_Missense_Mutation_p.S337R	NM_001184717.1	NP_001171646.1	Q7Z3E1	PARPT_HUMAN	TCDD-inducible poly(ADP-ribose) polymerase	337	WWE.	NA					NAD+ ADP-ribosyltransferase activity|nucleic acid binding|protein binding|zinc ion binding			NS(1)|breast(2)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(7)|lung(4)|ovary(2)|skin(2)|upper_aerodigestive_tract(2)	23			LUSC - Lung squamous cell carcinoma(72;0.0461)|Lung(72;0.0465)			CACCCTCTAGCAATGTCAACT	0.413		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(171;276 1987 3319 6837 11197)					NA		NA				0							NA				NA		147	145	146	NA	NA	NA	NA	3	NA	NA		NA						NA			NA				156411902		2203	4300	6503	SO:0001583	missense			ENSG00000163659	HGNC:23696	NM_015508	Approved	uc021xgg.1	NA	D3DNK6|Q68CY9|Q86VP4|Q9Y4P7	ENST00000461166.1	37	CCDS3177.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	12.23|12.23	1.876061|1.876061	0.33162|0.33162	.|.	.|.	ENSG00000163659|ENSG00000163659	ENST00000495891|ENST00000486483;ENST00000295924;ENST00000461166;ENST00000473702;ENST00000481853;ENST00000542783	.|T;T;T;T;T;T	.|0.34275	.|1.37;1.37;1.37;1.37;1.37;1.37	5.14|5.14	2.87|2.87	0.33458|0.33458	.|WWE domain (1);	.|0.514261	.|0.22320	.|N	.|0.061618	T|T	0.19127|0.19127	0.0459|0.0459	N|N	0.22421|0.22421	0.69|0.69	0.38157|0.38157	D|D	0.938924|0.938924	.|B	.|0.26002	.|0.139	.|B	.|0.24541	.|0.054	T|T	0.08006|0.08006	-1.0743|-1.0743	5|10	.|0.19590	.|T	.|0.45	.|.	4.7095|4.7095	0.12865|0.12865	0.0:0.5356:0.1574:0.307|0.0:0.5356:0.1574:0.307	.|.	.|337	.|Q7Z3E1	.|PARPT_HUMAN	K|R	40|337	.|ENSP00000418757:S337R;ENSP00000295924:S337R;ENSP00000420612:S337R;ENSP00000419982:S337R;ENSP00000418829:S337R;ENSP00000438345:S337R	.|ENSP00000295924:S337R	Q|S	+|+	1|3	0|2	TIPARP|TIPARP	157894596|157894596	0.983000|0.983000	0.35010|0.35010	1.000000|1.000000	0.80357|0.80357	0.994000|0.994000	0.84299|0.84299	1.247000|1.247000	0.32815|0.32815	0.967000|0.967000	0.38186|0.38186	0.655000|0.655000	0.94253|0.94253	CAA|AGC	TIPARP-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000351618.1	44.76088	KEEP		+	45.023206	0.414634	17	24	---	---	---	---	1	1	124	113	0	91	18	25	0	91	2	0	0	0	0	0	0	18	25	0	91	2	TP
YEATS2	55689	broad.mit.edu	37	3	183446551	183446551	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr3:183446551C>A	ENST00000305135.5	+	7	919	c.724C>A	c.(724-726)Cgt>Agt	p.R242S		NM_018023.4	NP_060493.3	Q9ULM3	YETS2_HUMAN	YEATS domain containing 2	242	YEATS.	NA			histone H3 acetylation|negative regulation of transcription from RNA polymerase II promoter	Ada2/Gcn5/Ada3 transcription activator complex	TBP-class protein binding			NS(1)|breast(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(9)|lung(24)|ovary(3)|prostate(2)|skin(3)	49	all_cancers(143;6.55e-10)|Ovarian(172;0.0303)		all cancers(12;2.38e-42)|Epithelial(37;1.9e-36)|OV - Ovarian serous cystadenocarcinoma(80;6.48e-22)			CCGAGGGTCCCGTAGAGAACC	0.413		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		117	119	118	NA	NA	NA	NA	3	NA	NA		NA						NA			NA				183446551		1850	4092	5942	SO:0001583	missense			ENSG00000163872	HGNC:25489	NM_018023	Approved	uc003fly.2	NA	A7E2B9|D3DNS9|Q641P6|Q9NW96	ENST00000305135.5	37	CCDS43175.1	.	.	.	.	.	.	.	.	.	.	C	21.6	4.168985	0.78339	.	.	ENSG00000163872	ENST00000421660;ENST00000305135	T	0.23147	1.92	5.47	5.47	0.80525	.	0.070420	0.56097	D	0.000032	T	0.27278	0.0669	N	0.16098	0.37	0.58432	D	0.999992	P	0.49253	0.921	P	0.55785	0.784	T	0.03017	-1.1082	10	0.31617	T	0.26	-11.6086	14.1927	0.65649	0.1496:0.8504:0.0:0.0	.	242	Q9ULM3	YETS2_HUMAN	S	242	ENSP00000306983:R242S	ENSP00000306983:R242S	R	+	1	0	YEATS2	184929245	0.992000	0.36948	0.998000	0.56505	0.989000	0.77384	2.813000	0.48002	2.553000	0.86117	0.563000	0.77884	CGT	YEATS2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000346507.2	-7.156176	KEEP		+	7.53275	0.056338	4	67	---	---	---	---	1	0.4691137	2	23	0	74	4	69	0	74	2	0	0	0	0	0	0	4	69	0	74	2	TP
SEC24D	9871	broad.mit.edu	37	4	119754779	119754779	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr4:119754779G>A	ENST00000379735.5	-	2	344	c.73C>T	c.(73-75)Cat>Tat	p.H25Y	SEC24D_ENST00000419654.2_5'UTR|SEC24D_ENST00000280551.6_Missense_Mutation_p.H25Y	NM_014822.2	NP_055637.2	O94855	SC24D_HUMAN	SEC24 family member D	25	Pro-rich.	NA			COPII vesicle coating|intracellular protein transport|post-translational protein modification|protein N-linked glycosylation via asparagine	COPII vesicle coat|cytosol|endoplasmic reticulum membrane|Golgi membrane|perinuclear region of cytoplasm	zinc ion binding			breast(3)|cervix(1)|endometrium(5)|kidney(1)|large_intestine(10)|lung(13)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	37						TGCCCATAATGAGGTGGAGAA	0.443		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		165	151	156	NA	NA	NA	NA	4	NA	NA		NA						NA			NA				119754779		2203	4300	6503	SO:0001583	missense			ENSG00000150961	HGNC:10706		Approved	uc003ici.4	NA	Q8IYI7	ENST00000379735.5	37		.	.	.	.	.	.	.	.	.	.	G	12.97	2.096897	0.37048	.	.	ENSG00000150961	ENST00000280551;ENST00000379735;ENST00000503683	T;T;T	0.75938	-0.97;-0.98;0.82	6.02	4.29	0.51040	.	0.284754	0.40302	N	0.001122	T	0.58409	0.2120	L	0.27053	0.805	0.80722	D	1	B;B	0.22909	0.077;0.046	B;B	0.28011	0.085;0.039	T	0.50136	-0.8863	10	0.02654	T	1	-20.0949	12.0758	0.53643	0.0:0.0:0.6862:0.3138	.	25;25	O94855-2;O94855	.;SC24D_HUMAN	Y	25	ENSP00000280551:H25Y;ENSP00000369059:H25Y;ENSP00000426309:H25Y	ENSP00000280551:H25Y	H	-	1	0	SEC24D	119974227	0.999000	0.42202	0.607000	0.28956	0.914000	0.54420	2.845000	0.48254	0.856000	0.35383	0.650000	0.86243	CAT	SEC24D-201	KNOWN	basic	protein_coding	NA	protein_coding		99.932937	KEEP		-	101.041529	0.390476	41	64	---	---	---	---	1	0.9999788	14	19	0	128	46	76	0	128	2	0	0	0	0	0	0	46	76	0	128	2	TP
OCLN	100506658	broad.mit.edu	37	5	68805542	68805542	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr5:68805542G>A	ENST00000355237.2	+	3	1061	c.625G>A	c.(625-627)Ggt>Agt	p.G209S	OCLN_ENST00000396442.2_Missense_Mutation_p.G209S|OCLN_ENST00000380766.2_Missense_Mutation_p.G209S|OCLN_ENST00000542132.1_Intron|OCLN_ENST00000538151.1_Intron	NM_002538.3	NP_002529.1	Q16625	OCLN_HUMAN	occludin	209	MARVEL.	NA			cellular component disassembly involved in apoptosis|protein complex assembly	integral to membrane|tight junction	protein binding|structural molecule activity			endometrium(2)|large_intestine(1)|liver(1)|prostate(1)|skin(1)	6		Lung NSC(167;4.15e-05)|Prostate(74;0.00996)|Ovarian(174;0.0448)|Breast(144;0.198)		OV - Ovarian serous cystadenocarcinoma(47;3.04e-60)|Epithelial(20;7.09e-58)|all cancers(19;1.13e-53)|Lung(70;0.0174)		ATCTCTATATGGTTCACAAAT	0.423		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		198	196	197	NA	NA	NA	NA	5	NA	NA		NA						NA			NA				68805542		2203	4300	6503	SO:0001583	missense			ENSG00000197822	HGNC:8104	NM_002538	Approved	uc003jwu.3	NA	B5BU70|Q8N6K1	ENST00000355237.2	37	CCDS4006.1	.	.	.	.	.	.	.	.	.	.	G	6.806	0.517859	0.13005	.	.	ENSG00000197822	ENST00000355237;ENST00000396442;ENST00000380766	T;T;D	0.83591	0.38;0.38;-1.74	5.81	-5.24	0.02789	Marvel (1);MARVEL-like domain (1);	0.662498	0.17321	N	0.178506	T	0.57036	0.2026	N	0.05574	-0.02	0.42351	D	0.992377	B	0.09022	0.002	B	0.11329	0.006	T	0.32561	-0.9902	10	0.11182	T	0.66	-40.9608	8.5879	0.33668	0.2281:0.0:0.5977:0.1742	.	209	Q16625	OCLN_HUMAN	S	209	ENSP00000347379:G209S;ENSP00000379719:G209S;ENSP00000370143:G209S	ENSP00000347379:G209S	G	+	1	0	OCLN	68841298	0.001000	0.12720	0.131000	0.22000	0.759000	0.43091	0.073000	0.14640	-0.630000	0.05567	0.650000	0.86243	GGT	OCLN-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000216794.1	208.35601	KEEP		+	208.91428	0.439306	76	97	---	---	---	---	1	1	70	87	0	146	84	103	0	146	2	0	0	0	0	0	0	84	103	0	146	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)					NA				NA		112	104	107	NA	NA	NA	NA	7	NA	NA		NA						NA			NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	42.723906	KEEP		-	42.878422	0.428571	15	20	---	---	---	---	1	0.9997411	19	9	0	58	15	22	0	58	2	1	1	230	304	3	599	15	22	0	58	8	TP
NOLC1	9221	broad.mit.edu	37	10	103921613	103921613	+	Silent	SNP	A	A	T			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr10:103921613A>T	ENST00000405356.1	+	12	2137	c.1902A>T	c.(1900-1902)ccA>ccT	p.P634P	NOLC1_ENST00000603742.1_Silent_p.P343P|NOLC1_ENST00000477977.1_3'UTR|NOLC1_ENST00000488254.2_Silent_p.P625P|NOLC1_ENST00000605788.1_Silent_p.P624P			Q14978	NOLC1_HUMAN	nucleolar and coiled-body phosphoprotein 1	624		NA			mitosis|rRNA processing	cytoplasm|nucleolus	ATP binding|GTP binding|protein binding			breast(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(12)|ovary(1)|upper_aerodigestive_tract(1)	31		Colorectal(252;0.122)		Epithelial(162;5.19e-08)|all cancers(201;9.43e-07)		CATCATCCCCATTCCGAAGGG	0.473		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		71	68	69	NA	NA	NA	NA	10	NA	NA		NA						NA			NA				103921613		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000166197	HGNC:15608	NM_004741	Approved	uc001kuo.2	NA	Q15030|Q5VV70|Q9BUV3	ENST00000405356.1	37																																																																																				NOLC1-201	KNOWN	basic	protein_coding	NA	protein_coding		70.599282	KEEP		+	71.471184	0.375	24	40	---	---	---	---	1	1	71	79	0	68	26	44	0	68	2	0	0	0	0	0	0	26	44	0	68	2	TP
SRSF5	6430	broad.mit.edu	37	14	70238061	70238061	+	Silent	SNP	C	C	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr14:70238061C>A	ENST00000553521.1	+	9	2155	c.702C>A	c.(700-702)ccC>ccA	p.P234P	SRSF5_ENST00000557154.1_Silent_p.P234P|SRSF5_ENST00000556587.1_3'UTR|SRSF5_ENST00000553635.1_Silent_p.P231P|SRSF5_ENST00000394366.2_Silent_p.P234P			Q13243	SRSF5_HUMAN	serine/arginine-rich splicing factor 5	234	Arg/Ser-rich (RS domain).	NA			mRNA 3'-end processing|mRNA export from nucleus|mRNA splice site selection|termination of RNA polymerase II transcription	nuclear speck	nucleotide binding|protein binding|RNA binding			large_intestine(1)|liver(1)	2						GTAGGTCTCCCGTGCCTGAGA	0.567		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		119	126	123	NA	NA	NA	NA	14	NA	NA		NA						NA			NA				70238061		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000100650	HGNC:10787	NM_001039465	Approved	uc001xlp.3	NA	O14797|Q16662|Q49AD6	ENST00000553521.1	37	CCDS32109.1																																																																																			SRSF5-003	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000412456.1	-31.861106	KEEP		+	7.22879	0.030864	5	157	---	---	---	---	1	0.9999909	2	1416	0	154	5	165	0	154	2	0	0	0	0	0	0	5	165	0	154	2	TP
LRRC37A2	474170	broad.mit.edu	37	17	44626432	44626432	+	Missense_Mutation	SNP	A	A	C			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr17:44626432A>C	ENST00000576629.1	+	10	4422	c.3927A>C	c.(3925-3927)aaA>aaC	p.K1309N	ARL17A_ENST00000337845.7_Intron|ARL17A_ENST00000445552.2_Intron|ARL17A_ENST00000573185.1_Intron|LRRC37A2_ENST00000333412.3_Missense_Mutation_p.K1309N|ARL17A_ENST00000329240.4_Intron			A6NM11	L37A2_HUMAN	leucine rich repeat containing 37, member A2	1309		NA				integral to membrane				endometrium(2)|kidney(1)|large_intestine(1)|lung(5)|pancreas(4)|prostate(2)	15		Melanoma(429;0.211)		BRCA - Breast invasive adenocarcinoma(366;0.232)		GCTTTCACAAAACTCGCTCCC	0.428		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		143	243	209	NA	NA	NA	NA	17	NA	NA		NA						NA			NA				44626432		2184	4296	6480	SO:0001583	missense			ENSG00000238083	HGNC:32404	NM_001006607	Approved	uc002ikn.1	NA		ENST00000576629.1	37	CCDS42353.1	.	.	.	.	.	.	.	.	.	.	a	11.77	1.736711	0.30774	.	.	ENSG00000238083	ENST00000333412	T	0.60920	0.15	2.35	1.25	0.21368	.	.	.	.	.	T	0.60314	0.2259	L	0.40543	1.245	0.09310	N	1	D;P;P	0.57899	0.981;0.865;0.779	D;P;B	0.67231	0.95;0.615;0.311	T	0.46721	-0.9171	9	0.72032	D	0.01	.	3.6001	0.08021	0.7951:0.0:0.2049:0.0	.	1309;270;1309	C9JSP5;B3KRJ4;A6NM11	.;.;L37A2_HUMAN	N	1309	ENSP00000333071:K1309N	ENSP00000333071:K1309N	K	+	3	2	LRRC37A2	41981748	0.000000	0.05858	0.015000	0.15790	0.017000	0.09413	0.488000	0.22371	1.090000	0.41315	0.147000	0.16070	AAA	LRRC37A2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000440299.2	175.878317	KEEP		+	198.532695	0.21865	68	243	---	---	---	---	1	0.999829	27	20	0	331	83	288	0	331	2	0	0	0	0	0	0	83	288	0	331	2	TP
DNMT1	1786	broad.mit.edu	37	19	10252778	10252778	+	Nonsense_Mutation	SNP	C	C	A			THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr19:10252778C>A	ENST00000340748.4	-	29	3422	c.3187G>T	c.(3187-3189)Gag>Tag	p.E1063*	DNMT1_ENST00000540357.1_Nonsense_Mutation_p.E1063*|DNMT1_ENST00000359526.4_Nonsense_Mutation_p.E1079*|DNMT1_ENST00000589538.1_5'UTR			P26358	DNMT1_HUMAN	DNA (cytosine-5-)-methyltransferase 1	1063	BAH 2.	NA			chromatin modification|maintenance of DNA methylation|negative regulation of histone H3-K9 methylation|negative regulation of transcription from RNA polymerase II promoter|positive regulation of gene expression|positive regulation of histone H3-K4 methylation|transcription, DNA-dependent	nucleus	DNA (cytosine-5-)-methyltransferase activity|DNA binding|transcription factor binding			breast(5)|endometrium(8)|kidney(5)|large_intestine(21)|lung(11)|ovary(2)|pancreas(1)|prostate(10)|skin(5)|stomach(1)|urinary_tract(1)	70			OV - Ovarian serous cystadenocarcinoma(20;1.59e-09)|Epithelial(33;2.86e-06)|all cancers(31;6.68e-06)		Azacitidine(DB00928)|Decitabine(DB01262)|Flucytosine(DB01099)|Ifosfamide(DB01181)|Procainamide(DB01035)	TCCCCATACTCCACGGTGCAG	0.637		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		88	67	74	NA	NA	NA	NA	19	NA	NA		NA						NA			NA				10252778		2203	4300	6503	SO:0001587	stop_gained				HGNC:2976	NM_001379	Approved	uc010xlc.2	NA	A0AV63|B7ZLW6|Q9UHG5|Q9ULA2|Q9UMZ6	ENST00000340748.4	37	CCDS12228.1	.	.	.	.	.	.	.	.	.	.	C	43	10.246826	0.99368	.	.	ENSG00000130816	ENST00000359526;ENST00000540357;ENST00000340748;ENST00000541266	.	.	.	5.36	4.31	0.51392	.	0.101437	0.64402	D	0.000004	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.07325	T	0.83	.	13.42	0.60992	0.0:0.9202:0.0:0.0798	.	.	.	.	X	1079;1063;1063;931	.	ENSP00000345739:E1063X	E	-	1	0	DNMT1	10113778	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	4.860000	0.62961	2.523000	0.85059	0.655000	0.94253	GAG	DNMT1-001	KNOWN	upstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000451166.1	2.974307	KEEP		-	7.377656	0.125	4	28	---	---	---	---	1	0.9964754	2	102	0	45	4	29	0	45	2	0	0	0	0	0	0	4	29	0	45	2	TP
FRG1B	0	broad.mit.edu	37	20	29628310	29628310	+	Silent	SNP	A	A	G	rs111939959|rs142255283		THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-ET-A25O-Tumor-SM-29SRC	THCA-TCGA-ET-A25O-Normal-SM-29SRG	g.chr20:29628310A>G	ENST00000278882.3	+	6	692	c.312A>G	c.(310-312)gcA>gcG	p.A104A	FRG1B_ENST00000358464.4_Silent_p.A104A|FRG1B_ENST00000439954.2_Silent_p.A109A						NA		NA								endometrium(10)|kidney(21)|lung(3)|pancreas(1)|prostate(9)|urinary_tract(9)	53						GTAAAACAGCAGGAGAAGAAG	0.358		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA				NA		NA	NA	NA	NA	NA	NA	NA		NA	NA		NA						NA			NA				NA		NA	NA	NA	SO:0001819	synonymous_variant								NA		ENST00000278882.3	37																																																																																				FRG1B-001	KNOWN	not_best_in_genome_evidence|basic	protein_coding	NA	protein_coding	OTTHUMT00000078494.2	0.598523	KEEP		+	6.688506	0.085714	3	32	---	---	---	---	1	0.522522	48	106	1	42	3	39	1	42	13	0	0	0	0	0	0	3	39	1	42	2	TP
